Braas K M, May V, Harakall S A, Hardwick J C, Parsons R L
Department of Anatomy and Neurobiology, The University of Vermont, College of Medicine, Burlington, Vermont 05405, USA.
J Neurosci. 1998 Dec 1;18(23):9766-79. doi: 10.1523/JNEUROSCI.18-23-09766.1998.
Cardiac output is regulated by the coordinate interactions of stimulatory sympathetic and inhibitory parasympathetic signals. Intracardiac parasympathetic ganglia are integrative centers of cardiac regulation, and modulation of the parasympathetic drive on the heart is accomplished by altering intrinsic cardiac ganglion neuron excitability. The pituitary adenylate cyclase-activating polypeptide (PACAP)/vasoactive intestinal peptide (VIP) family of peptides modulates cardiac function, and in guinea pig heart, PACAP appears to act directly on intrinsic parasympathetic cardiac ganglia neurons through PACAP-selective receptors. A multidisciplinary project tested whether cardiac PACAP peptides act through PACAP-selective receptors as excitatory neuromodulators amplifying the parasympathetic inhibition from guinea pig cardiac ganglia. The in vivo sources of regulatory PACAP peptides were localized immunocytochemically to neuronal fibers and a subpopulation of intrinsic postganglionic cardiac neurons. RT-PCR confirmed that cardiac ganglia expressed proPACAP transcripts and have PACAP peptide biosynthetic capabilities. Messenger RNA encoding PACAP-selective PAC1 receptor isoforms were also present in cardiac ganglia. Alternative splicing of PAC1 receptor transcripts produced predominant expression of the very short variant with neither HIP nor HOP cassettes; lower levels of the PAC1HOP2 receptor mRNA were present. Almost all of the parasympathetic neurons expressed membrane-associated PAC1 receptor proteins, localized immunocytochemically, which correlated with the population of cells that responded physiologically to PACAP peptides. PACAP depolarized cardiac ganglia neurons and increased neuronal membrane excitability. The rank order of peptide potency on membrane excitability in response to depolarizing currents was PACAP27>PACAP38>VIP. The PACAP-induced increase in excitability was not a function of membrane depolarization nor was it caused by alterations in action potential configuration. These results support roles for PACAP peptides as integrative modulators amplifying, through PACAP-selective receptors, the parasympathetic cardiac ganglia inhibition of cardiac output.
心输出量受刺激性交感神经和抑制性副交感神经信号的协同相互作用调节。心内副交感神经节是心脏调节的整合中心,通过改变心脏固有神经节神经元的兴奋性来实现对心脏副交感神经驱动的调节。垂体腺苷酸环化酶激活多肽(PACAP)/血管活性肠肽(VIP)肽家族调节心脏功能,在豚鼠心脏中,PACAP似乎通过PACAP选择性受体直接作用于心脏固有副交感神经节神经元。一个多学科项目测试了心脏PACAP肽是否通过PACAP选择性受体作为兴奋性神经调节剂发挥作用,增强豚鼠心脏神经节的副交感神经抑制作用。调节性PACAP肽的体内来源通过免疫细胞化学定位到神经纤维和心脏固有节后神经元的一个亚群。逆转录聚合酶链反应(RT-PCR)证实心脏神经节表达前PACAP转录本并具有PACAP肽生物合成能力。编码PACAP选择性PAC1受体亚型的信使核糖核酸(mRNA)也存在于心脏神经节中。PAC1受体转录本的可变剪接产生了既无HIP也无HOP盒的非常短变体的主要表达;存在较低水平的PAC1HOP2受体mRNA。几乎所有的副交感神经元都表达免疫细胞化学定位的膜相关PAC1受体蛋白,这与对PACAP肽产生生理反应的细胞群体相关。PACAP使心脏神经节神经元去极化并增加神经元膜兴奋性。在去极化电流作用下,肽对膜兴奋性的效力顺序为PACAP27>PACAP38>VIP。PACAP诱导的兴奋性增加既不是膜去极化的作用,也不是由动作电位构型改变引起的。这些结果支持PACAP肽作为整合调节剂的作用,通过PACAP选择性受体增强心脏副交感神经节对心输出量的抑制。